RNLX logo

Renalytix (RNLX) EBIT

Annual EBIT

-$28.89 M
+$13.34 M+31.59%

30 June 2024

RNLX EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$4.09 M
+$1.43 M+25.94%

30 September 2024

RNLX Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$24.74 M
+$4.80 M+16.24%

30 September 2024

RNLX TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNLX EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.6%+54.0%+37.2%
3 y3 years+19.3%+65.4%+41.4%
5 y5 years+31.8%-102.9%-1126.5%

RNLX EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+45.7%at high+71.8%at high+54.0%
5 y5 years-180.0%+45.7%-102.9%+71.8%-1126.5%+54.0%
alltimeall time-180.0%+45.7%-621.7%+71.8%-4263.1%+54.0%

Renalytix EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$4.09 M(-25.9%)
-$24.74 M(-16.2%)
June 2024
-$28.89 M(-31.6%)
-$5.53 M(-10.0%)
-$29.54 M(-13.0%)
Mar 2024
-
-$6.14 M(-31.7%)
-$33.95 M(-12.3%)
Dec 2023
-
-$8.99 M(+1.1%)
-$38.73 M(-1.7%)
Sept 2023
-
-$8.89 M(-10.5%)
-$39.39 M(-6.7%)
June 2023
-$42.22 M(-20.6%)
-$9.93 M(-9.0%)
-$42.22 M(-6.9%)
Mar 2023
-
-$10.92 M(+13.2%)
-$45.34 M(-7.4%)
Dec 2022
-
-$9.65 M(-17.7%)
-$48.96 M(-7.8%)
Sept 2022
-
-$11.72 M(-10.2%)
-$53.09 M(-0.2%)
June 2022
-$53.18 M
-$13.05 M(-10.2%)
-$53.18 M(-1.2%)
Mar 2022
-
-$14.54 M(+5.5%)
-$53.83 M(+13.7%)
DateAnnualQuarterlyTTM
Dec 2021
-
-$13.78 M(+16.7%)
-$47.37 M(+12.2%)
Sept 2021
-
-$11.81 M(-13.8%)
-$42.20 M(+17.9%)
June 2021
-$35.78 M(+246.9%)
-$13.70 M(+69.7%)
-$35.78 M(+43.3%)
Mar 2021
-
-$8.07 M(-6.3%)
-$24.97 M(+27.5%)
Dec 2020
-
-$8.61 M(+59.4%)
-$19.58 M(+42.9%)
Sept 2020
-
-$5.40 M(+87.2%)
-$13.70 M(+32.8%)
June 2020
-$10.31 M(-75.6%)
-$2.89 M(+7.6%)
-$10.31 M(+38.8%)
Mar 2020
-
-$2.68 M(-1.8%)
-$7.43 M(+56.5%)
Dec 2019
-
-$2.73 M(+35.4%)
-$4.75 M(+135.4%)
Sept 2019
-
-$2.02 M(+255.7%)
-$2.02 M(+255.7%)
June 2019
-$42.34 M
-
-
June 2018
-
-$567.00 K
-$567.00 K

FAQ

  • What is Renalytix annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Renalytix?
  • What is Renalytix annual EBIT year-on-year change?
  • What is Renalytix quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Renalytix?
  • What is Renalytix quarterly EBIT year-on-year change?
  • What is Renalytix TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Renalytix?
  • What is Renalytix TTM EBIT year-on-year change?

What is Renalytix annual earnings before interest & taxes?

The current annual EBIT of RNLX is -$28.89 M

What is the all time high annual EBIT for Renalytix?

Renalytix all-time high annual earnings before interest & taxes is -$10.24 M

What is Renalytix annual EBIT year-on-year change?

Over the past year, RNLX annual earnings before interest & taxes has changed by +$13.34 M (+31.59%)

What is Renalytix quarterly earnings before interest & taxes?

The current quarterly EBIT of RNLX is -$4.09 M

What is the all time high quarterly EBIT for Renalytix?

Renalytix all-time high quarterly earnings before interest & taxes is -$567.00 K

What is Renalytix quarterly EBIT year-on-year change?

Over the past year, RNLX quarterly earnings before interest & taxes has changed by +$4.80 M (+53.97%)

What is Renalytix TTM earnings before interest & taxes?

The current TTM EBIT of RNLX is -$24.74 M

What is the all time high TTM EBIT for Renalytix?

Renalytix all-time high TTM earnings before interest & taxes is -$567.00 K

What is Renalytix TTM EBIT year-on-year change?

Over the past year, RNLX TTM earnings before interest & taxes has changed by +$14.65 M (+37.19%)